Kamada Priced, Nasdaq: KMDA
Provides plasma-derived protein therapeutics mostly in Israel and the US.
Industry: Health Care
First Day Return: +9.2%
Industry: Health Care
KMDA
Provides plasma-derived protein therapeutics mostly in Israel and the US.
| IPO Data | |
|---|---|
| IPO File Date | 04/11/2013 |
| Offer Price | $9.25 |
| Price Range $10.81 - $10.81 | |
| Offer Shares (mm) | 5.6 |
| Deal Size ($mm) | $52 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/30/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $52 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Ness Ziona, Israel |
| Founded | 1990 |
| Employees at IPO | 292 |
| Website www.kamada.com | |
IPO News for Kamada
Kamada (KMDA) Performance
